These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 196436
1. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy]. Schwartzkopff W, Zschiedrich M. Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436 [No Abstract] [Full Text] [Related]
2. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V, Wechsler JG, Klör HU, Ditschuneit H. Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [Abstract] [Full Text] [Related]
3. [Familial hyperlipoproteinemia type III]. Patsch JR, Patsch W, Sailer S, Braunsteiner H. Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
4. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)]. Schwartzkopff W, Zschiedrich M. Med Klin; 1978 Feb 17; 73(7):231-9. PubMed ID: 203832 [Abstract] [Full Text] [Related]
5. Xanthomatosis and hyperlipoproteinemia; a review. Polano MK. Dermatologica; 1974 Feb 17; 149(1):1-9. PubMed ID: 4372111 [No Abstract] [Full Text] [Related]
6. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L, Olsson AG, Rössner S, Carlson LA. Postgrad Med J; 1975 Feb 17; 51(8):76-81. PubMed ID: 176639 [No Abstract] [Full Text] [Related]
7. Treatment of hyperlipidemia. Levy RI, Morganroth J, Rifkind BM. N Engl J Med; 1974 Jun 06; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
8. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR, Yeshurun D, Jackson RL, Gotto AM. Am J Med; 1977 Dec 06; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
9. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Hutt V, Wechsler JG, Klör HU, Ditschuneit H. Artery; 1980 Dec 06; 8(2):113-9. PubMed ID: 7458676 [Abstract] [Full Text] [Related]
10. [Hyperlipoproteinemia]. Meinders AE. Ned Tijdschr Geneeskd; 1979 Mar 14; 123(15):617-28. PubMed ID: 219378 [No Abstract] [Full Text] [Related]
11. [The when and how of therapy for hyperlipoproteinemia]. Mordasini R. Schweiz Med Wochenschr; 1978 Jan 28; 108(4):113-9. PubMed ID: 203028 [Abstract] [Full Text] [Related]
12. A physician's guide to hyperlipidemia. Fredrickson DS. Mod Concepts Cardiovasc Dis; 1972 Jul 28; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
14. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia]. Bucalossi A, Buzzelli G, D'Alessandro A. Clin Ter; 1979 Apr 30; 89(2):127-49. PubMed ID: 226307 [No Abstract] [Full Text] [Related]
15. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L, Olsson AG, Rössner S, Carlson LA. Postgrad Med J; 1975 Apr 30; 51(8):suppl 76-81. PubMed ID: 215986 [Abstract] [Full Text] [Related]